Dress shoes represent 57.0% of product demand and outpatient accounts for 58.0% of patient type sales in 2026. The diabetic shoes market was valued at USD 9.7 billion in 2025, is projected to reach USD 19.3 billion by 2036 and is forecast to post a 6.4% CAGR between 2026 and 2036.